EREZ FEIGE, PH.D., MBA

Dr. Erez Feige, Ph.D., M.B.A. previously served as SVP Business Operations at VBL Therapeutics (Nasdaq: VBLT) and is one of the inventors of the Monocyte Targeting Technology . He brings over 17 years of experience in business development, strategic planning, intellectual property and investor relations and helped raise over $180 million in equity capital and non-dilutive sources. 

Dr. Feige has scientific expertise in cancer, immunology, biochemistry and molecular biology and was involved in the development various technologies and pipeline products. Dr. Feige received a doctor of philosophy degree and a master’s of business administration degree from Bar-Ilan University in Ramat Gan, Israel and completed a post-doctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School in Boston.